Efficacy and safety of bevacizumab in combination with fluoropyrimidine-based chemotherapy for the treatment of advanced metastatic colorectal cancer: a prospective, non-intervention and post-marketing multicenter clinical study (REACT)

REACT Clinical Research Group

doi:10.3969/j.issn.1009-0460.2016.10.001

Home>Articles>Efficacy and safety of bevacizumab in combination with fluoropyrimidine-based chemotherapy for the treatment of advanced metastatic colorectal cancer: a prospective, non-intervention and post-marketing multicenter clinical study (REACT)

DOI: 10.3969/j.issn.1009-0460.2016.10.001

Efficacy and safety of bevacizumab in combination with fluoropyrimidine-based chemotherapy for the treatment of advanced metastatic colorectal cancer: a prospective, non-intervention and post-marketing multicenter clinical study (REACT)

REACT Clinical Research Group

Keywords：Chinese patientsColorectal cancer/Advanced and metastaticBevacizumabCombined chemotherapy/Fluorouracil drugsSafety/Efficiency

Publication Date：2016-01-01

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：9( 865-873 )

Chinese Clinical Oncology

PKUISTIC

ISSN：1009-0460

Year, Vol.(Issue)：2016,21(10)